Inventor · disambiguated record
William Michael Kavanaugh
Also filed as: KAVANAUGH WILLIAM M · KAVANAUGH WILLIAM MICHAEL
8 granted patents·9 pending applications·92 citations·filing 1994–2018
87Inventor score
Files withNOVARTIS VACCINES & DIAGNOSTICS INC4KAVANAUGH WILLIAM M3UNIV CALIFORNIA3NOVARTIS AG2CHIRON CORP1
Top patents by PatentIndex Score
17 records- 0189US9926371B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2016·Granted Mar 27, 2018·7 cites·17 claims
- 0289US9079956B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Granted Jul 14, 2015·11 cites·30 claims
- 0383US6280964B1Binding sites for phosphotyrosine binding domainsUNIV CALIFORNIA·Filed 1995·Granted Aug 28, 2001·42 cites·19 claims
- 0476US8652469B2M-CSF-specific monoclonal antibody and uses thereofKAVANAUGH WILLIAM M·Filed 2006·Granted Feb 18, 2014·10 cites·13 claims
- 0572US9522186B2M-CSF specific monoclonal antibody and uses therofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2015·Granted Dec 20, 2016·1 cites·22 claims
- 0669US11034759B2Humanized M-CSF specific monoclonal antibodies, kits, and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Granted Jun 15, 2021·0 cites·27 claims
- 0763US5744313AAssay employing novel protein domain which binds tyrosine phosphorylated proteinsUNIV CALIFORNIA·Filed 1994·Granted Apr 28, 1998·15 cites·21 claims
- 0861US2018171009A1M-CSF Specific Monoclonal Antibody and Uses ThereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2018·Application pending·0 cites
- 0956US2009324604A1M-csf specific monoclonal antibody and uses thereofCHIRON CORP·Filed 2005·Application pending·0 cites
- 1054US2014030738A1Soluble human m-csf receptor and uses thereofXOMA TECHNOLOGY LTD·Filed 2013·Application pending·0 cites
- 1152US2014093492A1Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasisZIMMERMAN DEBORAH LEE·Filed 2013·Application pending·0 cites
- 1251US2015050280A1Soluble human m-csf receptor and uses thereofNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1351US2008233118A1Uses Of Antibody To M-CsfNOVARTIS AG·Filed 2006·Application pending·0 cites
- 1449US2011091451A1Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasisKAVANAUGH WILLIAM M·Filed 2004·Application pending·0 cites
- 1547US5925547ANucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteinsUNIV CALIFORNIA·Filed 1995·Granted Jul 20, 1999·6 cites·13 claims
- 1645US2002156236A1Binding sites for phosphotyrosine binding domainsFiled 2001·Application pending·0 cites
- 1745US2012045450A1Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasisKAVANAUGH WILLIAM M·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Michael Kavanaugh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →